Helicobacter Pylori Testing Market Size By Test Type (Invasive {Histology, Rapid Urease Test (RUT), HP Culture}, Non-Invasive {Serologic Test, Urea Breath Test (UBT), Stool Antigen Test (SAT)}), By Method (Point-of-care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Japan, Romania, Russia, China, India, Australia, South Korea, Brazil, Mexico, Chile, Argentina, South Africa, Saudi Arabia, Nigeria, Turkey), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025


Helicobacter Pylori Market is expected to exceed USD 560 million by 2025. The rising prevalence of gastric ulcer across the globe is leading toward the adoption of non-invasive diagnostics solutions. 

Some major findings of the helicobacter pylori market report include:
     - 	The leading factors contributing significantly to development of market are increase in geriatric population & growing cases of numerous infectious diseases 

     - 	Urea breath test is gaining popularity for its rapid diagnostics capability, safety and high sensitivity for detecting H. pylori infection. An approximate one of six entities infected with H. pylori are likely to develop peptic ulcer disorder.
 
     - 	Major players operating in the helicobacter pylori market market are Abbott, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, Meridian Biosciences, Quidel Corporation and Thermo Fisher

     - 	The companies operating in the market are focusing on development of advanced diagnostics kits

     - 	Exalenz Bioscience Ltd. has announced that the China Food and Drug Administration has permitted Exalenz to initiate marketing and selling its BreathID Hp Lab System for detection of H. pylori bacteria

Technological advancements & innovations in H. pylori infection testing results in greater consumer satisfaction that will accelerate market growth. H. pylori is prominently found in patients suffering from gastric and duodenal ulcers. Guidelines of American College of Gastroenterology (ACG) recommend diagnostic tests to confirm eradication of H. pylori with prior to prescribing a proton pump inhibitor (PPI) for patients with no alarm symptoms such as gastrointestinal bleeding, odynophagia, early satiety, anemia, progressive dysphagia, vomiting, gastrointestinal cancer. etc. Thus, soaring occurrence of symptoms associated with gastric ulcers will fuel the business expansion. Furthermore, escalating demand for diagnostics at relatively lower prices will augment the industry growth in the forthcoming years.

A number of non-invasive tests such as urea breath test (UBT), stool antigen test (SAT) are chosen over invasive methods that includes usage of endoscopy for biopsy. Serology test is comparatively less expensive option for detection of H. pylori infection. It is specifically suitable for testing large numbers, while UBT delivers accurate results. UBT has advantage of being free from sampling error, since the whole stomach is involved. It detects only current infection, thus confirming successful eradication of H. pylori after treatment. For instance, American Gastroenterological Association (AGA) recommends non-invasive active testing methods such as urea breath test and stool antigen test. Thereby, benefits such as rapid diagnosis coupled with availability of cost-effective testing kits are responsible for rising adoption of non-invasive methods contributing to the overall market growth.

Point-of-care testing is less expensive and gives accurate results in short time span. The firms operating in the market are focusing on development of advanced diagnostics kits. The new product development for H. pylori testing is expected to propel growth of market in coming years. Persons with one or more disease conditions are usually at more risk and require early disease detection and management. Easy availability of various invasive & non-invasive devices suitable to patients according to their physiological features and high accessibility of POC testing will aid the segmental growth. Moreover, the rising initiatives by various government organizations to control target diseases and reduce the disease burden would positively impact on point of care testing industry growth. 

The Middle East and Africa H. pylori testing market accounted for significant growth and is assessed to witness a considerable CAGR of 7.9% by 2025. The expansion is attributed to progress in healthcare facilities, development in infrastructure and growing public expenditure on the treatment of H. pylori infections in the region. Conferring to the United Nations, EMBASE & MEDLINE databases, in 2015, Africa had maximum prevalence of 70% of H. pylori infection. Also, the growing prevalence of cancer and peptic ulcers in this region is expected to drive market growth over the forthcoming years. Additionally, rising involvement of government to promote training of human resources available for H. pylori testing solutions will positively impact regional expansion during the forecast period.

At present, various firms have developed sequencing and analysis instruments. Escalating demand for adoption of advanced technologies coupled with rising number of firms offering innovative H. pylori testing solutions will augment market expansion. Few of the prominent players operating in Helicobacter pylori testing industry are Abbott, Bio-Rad Laboratories, Inc., Cardinal Health, Quidel Corporation, Meridian Biosciences and Thermo Fisher. Market players are involved in various strategic alliances such as mergers & acquisitions, partnerships, and collaborations with other contributors to acquire significant revenue shares and competitive advantage over other market players. For instance, in October 2018, DiaSorin and Meridian Bioscience, Inc. strategically collaborated to sell DiaSorin?s FDA-cleared Helicobacter pylori stool antigen test to identify H. pylori for use on its automated LIAISON platform under the Meridian brand name worldwide.
Report Content
 
 Chapter 1. Methodology 
 
 1.1. Methodology
 
 1.2. Market definitions
 
 1.3. Forecast parameters
 
 1.4. Data Sources
 
 1.4.1. Secondary
 
 1.4.1.1. Paid sources
 
 1.4.1.2. Unpaid sources
 
 1.4.2. Primary
 
 Chapter 2. Executive Summary
 
 2.1. Helicobacter pylori testing industry 360 degree synopsis, 2014 - 2025 (USD Million)
 
 2.1.1. Business trends
 
 2.1.2. Product trends
 
 2.1.3. Method trends
 
 2.1.4. End-use trends
 
 2.1.5. Regional trends
 
 Chapter 3. Helicobacter Pylori Testing Industry Insights
 
 3.1. Industry segmentation
 
 3.2. Industry landscape, 2014 - 2025
 
 3.3. Industry impact forces
 
 3.3.1. Growth drivers
 
 3.3.1.1. Rise in prevalence of gastric ulcer
 
 3.3.1.2. Increasing elderly population in Asia Pacific countries
 
 3.3.1.3. Growing demand for point of care testing devices
 
 3.3.1.4. Rising adoption of non-invasive H. pylori testing
 
 3.3.2. Industry pitfalls & challenges
 
 3.3.2.1. Lack of skilled professionals for invasive testing
 
 3.3.2.2. Lack of awareness regarding H. Pylori infection
 
 3.4. Growth potential analysis
 
 3.4.1. By test type
 
 3.4.2. By method
 
 3.4.3. By end-use
 
 3.5. Regulatory landscape
 
 3.6. Reimbursement scenario
 
 3.7. Technology landscape
 
 3.8. Pricing Analysis
 
 3.9. Porter's analysis
 
 3.10. Competitive landscape, 2018
 
 3.10.1. Strategy dashboard
 
 3.11. PESTEL analysis
 
 Chapter 4. Helicobacter Pylori Testing Market, By Test Type
 
 4.1. Helicobacter pylori testing market share by test type, 2018 & 2025
 
 4.2. Invasive
 
 4.2.1. Market size, 2014 - 2025 (USD Million)
 
 4.2.2. Histology
 
 4.2.2.1. Market size, 2014 - 2025 (USD Million)
 
 4.2.3. Rapid urease test
 
 4.2.3.1. Market size, 2014 - 2025 (USD Million)
 
 4.2.4. HP culture
 
 4.2.4.1. Market size, 2014 - 2025 (USD Million)
 
 4.3. Non-invasive
 
 4.3.1. Market size, 2014 - 2025 (USD Million)
 
 4.3.2. Serologic Test
 
 4.3.2.1. Market size, 2014 - 2025 (USD Million)
 
 4.3.3. Urea Breath Test (UBT)
 
 4.3.3.1. Market size, 2014 - 2025 (USD Million)
 
 4.3.4. Stool Antigen Test (SAT)
 
 4.3.4.1. Market size, 2014 - 2025 (USD Million)
 
 Chapter 5. Helicobacter Pylori Testing Market, By Method
 
 5.1. Helicobacter pylori testing market share by method, 2018 & 2025
 
 5.2. Point of care (POC) test
 
 5.2.1. Market size, 2014 - 2025 (USD Million)
 
 5.3. Laboratory based test
 
 5.3.1. Market size, 2014 - 2025 (USD Million)
 
 Chapter 6. Helicobacter Pylori Testing Market, By End-use
 
 6.1. Helicobacter pylori testing market share by end-use, 2018 & 2025
 
 6.2. Hospitals
 
 6.2.1. Market size, 2014 - 2025 (USD Million)
 
 6.3. Clinics
 
 6.3.1. Market size, 2014 - 2025 (USD Million)
 
 6.4. Diagnostic laboratories
 
 6.4.1. Market size, 2014 - 2025 (USD Million)
 
 6.5. Others
 
 6.5.1. Market size, 2014 - 2025 (USD Million)
 
 Chapter 7. Helicobacter Pylori Testing Market, By Region
 
 7.1. Key regional trends
 
 7.2. North America
 
 7.2.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
 
 7.2.2. Market estimates and forecast, By test type, 2014 - 2025 (USD Million)
 
 7.2.2.1. Market estimates and forecast, by invasive, 2014 - 2025 (USD Million)
 
 7.2.2.2. Market estimates and forecast, by non-invasive, 2014 - 2025 (USD Million)
 
 7.2.3. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.2.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.2.5. U.S.
 
 7.2.5.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.2.5.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.2.5.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.2.5.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.2.6. Canada
 
 7.2.6.1. Market estimates and forecast, By test type, 2014 - 2025 (USD Million)
 
 7.2.6.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.2.6.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.2.6.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.3. Europe
 
 7.3.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
 
 7.3.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.3.3. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.3.3.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.3.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.3.5. Germany
 
 7.3.5.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.3.5.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.3.5.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.3.5.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.3.6. UK
 
 7.3.6.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.3.6.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.3.6.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.3.6.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.3.7. France
 
 7.3.7.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.3.7.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.3.7.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.3.7.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.3.8. Italy
 
 7.3.8.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.3.8.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.3.8.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.3.8.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.3.9. Spain
 
 7.3.9.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.3.9.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.3.9.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.3.9.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.4. Asia Pacific
 
 7.4.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
 
 7.4.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.4.3. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.4.3.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.4.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.4.5. China
 
 7.4.5.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.4.5.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.4.5.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.4.5.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.4.6. Japan
 
 7.4.6.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.4.6.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.4.6.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.4.6.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.4.7. India
 
 7.4.7.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.4.7.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.4.7.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.4.7.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.4.8. Australia
 
 7.4.8.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.4.8.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.4.8.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.4.8.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.5. Latin America
 
 7.5.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
 
 7.5.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.5.3. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.5.3.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.5.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.5.5. Brazil
 
 7.5.5.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.5.5.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.5.5.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.5.5.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.5.6. Mexico
 
 7.5.6.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.5.6.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.5.6.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.5.6.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.5.7. Argentina
 
 7.5.7.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.5.7.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.5.7.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.5.7.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.6. MEA
 
 7.6.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
 
 7.6.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.6.3. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.6.3.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.6.4. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.6.5. South Africa
 
 7.6.5.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.6.5.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.6.5.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.6.5.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 7.6.6. Saudi Arabia
 
 7.6.6.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
 
 7.6.6.2. Market estimates and forecast, by method, 2014 - 2025 (USD Million)
 
 7.6.6.2.1. Market estimates and forecast, by point of care (POC) test, 2014 - 2025 (USD Million)
 
 7.6.6.3. Market estimates and forecast, by end-use, 2014 - 2025 (USD Million)
 
 Chapter 8. Company Profiles
 
 8.1. Abbott
 
 8.1.1. Business Overview
 
 8.1.2. Financial data
 
 8.1.3. Product landscape
 
 8.1.4. Strategic outlook
 
 8.1.5. SWOT analysis
 
 8.2. Avanos Corporate
 
 8.2.1. Business Overview
 
 8.2.2. Financial data
 
 8.2.3. Product landscape
 
 8.2.4. Strategic outlook
 
 8.2.5. SWOT analysis
 
 8.3. Biohit Oyj
 
 8.3.1. Business Overview
 
 8.3.2. Financial data
 
 8.3.3. Product landscape
 
 8.3.4. Strategic outlook
 
 8.3.5. SWOT analysis
 
 8.4. Bio-Rad Laboratories, Inc.
 
 8.4.1. Business overview
 
 8.4.2. Financial data
 
 8.4.3. Product landscape
 
 8.4.4. Strategic outlook
 
 8.4.5. SWOT analysis
 
 8.5. Cardinal Health
 
 8.5.1. Business overview
 
 8.5.2. Financial data
 
 8.5.3. Product landscape
 
 8.5.4. Strategic outlook
 
 8.5.5. SWOT analysis
 
 8.6. Exalenz Bioscience Ltd.
 
 8.6.1. Business overview
 
 8.6.2. Financial data
 
 8.6.3. Product landscape
 
 8.6.4. Strategic outlook
 
 8.6.5. SWOT analysis
 
 8.7. Gulf Coast Scientific
 
 8.7.1. Business overview
 
 8.7.2. Financial data
 
 8.7.3. Product landscape
 
 8.7.4. Strategic outlook
 
 8.7.5. SWOT analysis
 
 8.8. Medline Industries, Inc.
 
 8.8.1. Business overview
 
 8.8.2. Financial data
 
 8.8.3. Product landscape
 
 8.8.4. Strategic outlook
 
 8.8.5. SWOT analysis
 
 8.9. Meridian Biosciences
 
 8.9.1. Business overview
 
 8.9.2. Financial data
 
 8.9.3. Product landscape
 
 8.9.4. Strategic outlook
 
 8.9.5. SWOT analysis
 
 8.10. Quidel Corporation
 
 8.10.1. Business overview
 
 8.10.2. Financial data
 
 8.10.3. Product landscape
 
 8.10.4. Strategic outlook
 
 8.10.5. SWOT analysis
 
 8.11. Thermo Fisher Scientific
 
 8.11.1. Business overview
 
 8.11.2. Financial data
 
 8.11.3. Product landscape
 
 8.11.4. Strategic outlook
 
 8.11.5. SWOT analysis

Data Tables TABLE 1 Helicobacter pylori testing industry 360 degree synopsis, 2014-2025 TABLE 2 Global helicobacter pylori testing market, 2014-2025 (USD Million) TABLE 3 Global helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 4 Global helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 5 Global helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 6 Million) TABLE 7 Global helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 8 Global helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 9 Global helicobacter pylori testing market, by region, 2014-2025 (USD Million) TABLE 10 Industry impact force analysis TABLE 11 Invasive market, by region, 2014-2025 (USD Million) TABLE 12 Histology market, by region, 2014-2025 (USD Million) TABLE 13 Rapid urease test market, by region, 2014-2025 (USD Million) TABLE 14 HP culture market, by region, 2014-2025 (USD Million) TABLE 15 Non-invasive market, by region, 2014-2025 (USD Million) TABLE 16 Serologic test market, by region, 2014-2025 (USD Million) TABLE 17 Urea breath test (UBT) market, by region, 2014-2025 (USD Million) TABLE 18 Stool antigen test (SAT) market, by region, 2014-2025 (USD Million) TABLE 19 Point of care (POC) test market, by region, 2014-2025 (USD Million) TABLE 20 Laboratory based test market, by region, 2014-2025 (USD Million) TABLE 21 Clinics market, by region, 2014-2025 (USD Million) TABLE 22 Hospitals market, by region, 2014-2025 (USD Million) TABLE 23 Others market, by region, 2014-2025 (USD Million) TABLE 24 Diagnostic laboratories market, by region, 2014-2025 (USD Million) TABLE 25 North America helicobacter pylori testing market, by country, 2014-2025 (USD Million) TABLE 26 North America helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 27 North America helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 28 North America helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 29 North America helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 30 North America helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 31 U.S. helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 32 U.S. helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 33 U.S. helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 34 U.S. helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 35 U.S. helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 36 Canada helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 37 Canada helicobacter pylori testing market, by invasive, 2014-20125 (USD Million) TABLE 38 Canada helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 39 Canada helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 40 Canada helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 41 Europe helicobacter pylori testing market, by country, 2014-2025 (USD Million) TABLE 42 Europe helicobacter pylori testing market, By test type, 2014-2025 (USD Million) TABLE 43 Europe helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 44 Europe helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 45 Europe helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 46 Europe helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 47 Germany helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 48 Germany helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 49 Germany helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 50 Germany helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 51 Germany helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 52 UK helicobacter pylori testing market, By test type, 2014-2025 (USD Million) TABLE 53 UK helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 54 UK helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 55 UK helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 56 UK helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 57 France helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 58 France helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 59 France helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 60 France helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 61 France helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 62 Italy helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 63 Italy helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 64 Italy helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 65 Italy helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 66 Spain helicobacter pylori testing market, By test type, 2014-2025 (USD Million) TABLE 67 Spain helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 68 Spain helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 69 Spain helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 70 Spain helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 71 Russia helicobacter pylori testing market, By test type, 2014-2025 (USD Million) TABLE 72 Russia helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 73 Russia helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 74 Russia helicobacter pylori testing market, by method, 2014 - 2025 (USD Million) TABLE 75 Russia helicobacter pylori testing market, by end-use, 2014 - 2025 (USD Million) TABLE 76 Romania helicobacter pylori testing market, By test type, 2014-2025 (USD Million) TABLE 77 Romania helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 78 Romania helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 79 Romania helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 80 Romania helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 81 Asia Pacific helicobacter pylori testing market, by country, 2014-2025 (USD Million) TABLE 82 Asia Pacific helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 83 Asia Pacific helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 84 Asia Pacific helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 85 Asia Pacific helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 86 Asia Pacific helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 87 Japan helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 88 Japan helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 89 Japan helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 90 Japan helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 91 Japan helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 92 China helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 93 China helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 94 China helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 95 China helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 96 China helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 97 India helicobacter pylori testing market, By test type, 2014-2025 (USD Million) TABLE 98 India helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 99 India helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 100 India helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 101 India helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 102 Australia helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 103 Australia helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 104 Australia helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 105 Australia helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 106 Australia helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 107 South Korea helicobacter pylori testing market, By test type, 2014-2025 (USD Million) TABLE 108 South Korea helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 109 South Korea helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 110 South Korea helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 111 South Korea helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 112 Latin America Helicobacter pylori testing market, by country, 2014-2025 (USD Million) TABLE 113 Latin America helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 114 Latin America helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 115 Latin America helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 116 Latin America helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 117 Latin America helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 118 Brazil helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 119 Brazil helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 120 Brazil helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 121 Brazil helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 122 Brazil helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 123 Chile helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 124 Chile helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 125 Chile helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 126 Chile helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 127 Chile helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 128 Mexico helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 129 Mexico helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 130 Mexico helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 131 Mexico helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 132 Mexico helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 133 Argentina helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 134 Argentina helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 135 Argentina helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 136 Argentina helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 137 Argentina helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 138 Middle East & Africa helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 139 Middle East & Africa helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 140 Middle East & Africa helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 141 Middle East & Africa helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 142 Middle East & Africa helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 143 South Africa helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 144 South Africa helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 145 South Africa helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 146 South Africa helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 147 South Africa helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 148 Saudi Arabia helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 149 Saudi Arabia helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 150 Saudi Arabia helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 151 Saudi Arabia helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 152 Saudi Arabia helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 153 Turkey helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 154 Turkey helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 155 Turkey helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 156 Turkey helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 157 Turkey helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) TABLE 158 Nigeria helicobacter pylori testing market, by test type, 2014-2025 (USD Million) TABLE 159 Nigeria helicobacter pylori testing market, by invasive, 2014-2025 (USD Million) TABLE 160 Nigeria helicobacter pylori testing market, by non-invasive, 2014-2025 (USD Million) TABLE 161 Nigeria helicobacter pylori testing market, by method, 2014-2025 (USD Million) TABLE 162 Nigeria helicobacter pylori testing market, by end-use, 2014-2025 (USD Million) Charts & Figures Figure 1. Industry segmentation Figure 2. Global helicobacter pylori testing market, 2014 - 2025 (USD Million) Figure 3. Growth potential analysis, by test type Figure 4. Growth potential analysis, by method Figure 5. Growth potential analysis, by end-use Figure 6. Pricing Analysis Figure 7. Porter's analysis Figure 8. Strategic dashboard Figure 9. PESTEL analysis

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by Global Market Insights, Inc.

Industrial & Residential Heating Market Size By Wood & Pellet Heating (Fireplaces, Catalytic Wood Stoves, Masonry Heaters, Boilers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026

Industrial & Residential Heating Market will witness an annual deployment of over 2 million units by 2026. Economic escalation along with ongoing urbanization and industrialization is positively influencing the installation for these units. Some majo...

New Pharmaceuticals and Healthcare Reports

Publisher: Global Market Insights, Inc.